Cardiology

Drug-Eluting stents offer no advantage for A-Fib patients

(HealthDay) -- Drug-eluting stents (DESs) do not seem to offer advantages over bare-metal stents (BMSs) for patients with atrial fibrillation (AF) who undergo percutaneous coronary intervention (PCI) with stent implantation, ...

Cardiology

Stents disrupt blood flow

(Medical Xpress)—A researcher at ETH Zurich is designing a realistic artery model with an implanted stent and is using a computer to simulate the blood flow through the stent. In doing so he is uncovering weaknesses in ...

Cardiology

Aspiration noninferior to stent retriever for clot removal

(HealthDay)—Aspiration is as effective as the traditional stent retriever approach for clot removal in patients presenting with large-vessel occlusion stroke, according to a study published online March 9 in The Lancet.

Cardiology

Good long-term outcomes for drug-eluting stents

(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, or recurrent ...

page 11 from 34